Praxis Precision Medicines (PRAX) EPS (Weighted Average and Diluted) (2020 - 2026)
Praxis Precision Medicines (PRAX) recorded quarterly EPS (Weighted Average and Diluted) of -$3.2 in Q1 2026, up 8.83% quarter-over-quarter from -$3.51 in Q4 2025, and up 2.74% on a YoY basis from -$3.11 in Q1 2025.
Praxis Precision Medicines (PRAX) EPS (Weighted Average and Diluted) (2020 - 2026) Analysis & Trends
Praxis Precision Medicines' EPS (Weighted Average and Diluted) history runs 7 years deep, the most recent figure standing at -$3.2 for Q1 2026.
- In Q1 2026, EPS (Weighted Average and Diluted) rose 2.74% year-over-year to -$3.2; the TTM figure through Mar 2026 stood at -$13.38 (down 24.12% YoY), while the FY2025 annual figure was -$13.48, down 32.03% from the prior year.
- EPS (Weighted Average and Diluted) was -$3.2 for Q1 2026 at Praxis Precision Medicines, up from -$3.51 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.96 in Q3 2022 to a low of -$65.86 in Q4 2022.
- Historically, EPS (Weighted Average and Diluted) has averaged -$7.02 across 5 years, with a median of -$3.0 in 2024.
- The sharpest annual moves came in 2022 and 2023: EPS (Weighted Average and Diluted) sank 4851.88% in 2022, then jumped 97.02% in 2023.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$65.86 in 2022, then surged by 97.02% to -$1.96 in 2023, then tumbled by 53.06% to -$3.0 in 2024, then fell by 17.0% to -$3.51 in 2025, then rose by 8.83% to -$3.2 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$3.2 (Q1 2026), -$3.51 (Q4 2025), and -$3.36 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.61 |
| 10 | Praxis Precision Medicines | 200.22 Mn | -586.65 Mn | - | -3.20 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.20 |
| Dec 31, 2025 | -3.51 |
| Sep 30, 2025 | -3.36 |
| Jun 30, 2025 | -3.31 |
| Mar 31, 2025 | -3.29 |
| Dec 31, 2024 | -3.00 |
| Sep 30, 2024 | -2.75 |
| Jun 30, 2024 | -1.74 |
| Mar 31, 2024 | -2.84 |
| Dec 31, 2023 | -1.96 |
| Sep 30, 2023 | -2.72 |
| Jun 30, 2023 | -7.38 |
| Mar 31, 2023 | -10.58 |
| Dec 31, 2022 | -65.86 |
| Sep 30, 2022 | -0.96 |
| Jun 30, 2022 | -1.32 |
| Mar 31, 2022 | -1.51 |
| Dec 31, 2021 | -1.33 |
| Sep 30, 2021 | -1.00 |
| Jun 30, 2021 | -0.88 |